R J Mandel|P K Randall - JoVE Visualize

Showing results (81-90 of 91) with videos related to

Pageof 10

Sort By:

Psychoneuroendocrinology|January 1, 1987

Genotypic influences on pituitary responsiveness to haloperidol in miceD G Morgan, J S Randall, N A Telford, et al.

Biological Psychiatry|September 1, 1995

Effects of the benzodiazepine antagonist flumazenil in PTSDP K Randall, J D Bremner, J H Krystal, et al.

Brain Research|August 27, 1990

Behavioral sensitization following subchronic apomorphine treatment--possible neurochemical basisD M Vaughn, J A Severson, J J Woodward, et al.

Alcoholism, Clinical and Experimental Research|July 11, 2000

Dissociation between the time course of ethanol and extracellular dopamine concentrations in the nucleus accumbens after a single intraperitoneal injectionH J Yim, D L Robinson, M L White, et al.

Neuropharmacology|May 1, 1996

Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell linesC K Mak, M Avalos, P K Randall, et al.

European Journal of Neurology|November 23, 2006

LRRK2 mutations in a clinic-based cohort of Parkinson's diseaseS Scholz, R J Mandel, H H Fernandez, et al.

Experimental Neurology|March 1, 1997

Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's diseaseK S Bankiewicz, S E Leff, D Nagy, et al.

Molecular Pharmacology|February 1, 1992

Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathioneS W Leslie, L M Brown, R D Trent, et al.

Gene Therapy|May 9, 2014

Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathwaysS E Gombash, F P Manfredsson, R J Mandel, et al.

Nature Biotechnology|August 14, 1998

Regulation of gene expression in vivo following transduction by two separate rAAV vectorsK G Rendahl, S E Leff, G R Otten, et al.

Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:

Pageof 10

Psychoneuroendocrinology|January 1, 1987

Genotypic influences on pituitary responsiveness to haloperidol in miceD G Morgan, J S Randall, N A Telford, et al.

Biological Psychiatry|September 1, 1995

Effects of the benzodiazepine antagonist flumazenil in PTSDP K Randall, J D Bremner, J H Krystal, et al.

Brain Research|August 27, 1990

Behavioral sensitization following subchronic apomorphine treatment--possible neurochemical basisD M Vaughn, J A Severson, J J Woodward, et al.

Alcoholism, Clinical and Experimental Research|July 11, 2000

Dissociation between the time course of ethanol and extracellular dopamine concentrations in the nucleus accumbens after a single intraperitoneal injectionH J Yim, D L Robinson, M L White, et al.

Neuropharmacology|May 1, 1996

Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell linesC K Mak, M Avalos, P K Randall, et al.

European Journal of Neurology|November 23, 2006

LRRK2 mutations in a clinic-based cohort of Parkinson's diseaseS Scholz, R J Mandel, H H Fernandez, et al.

Experimental Neurology|March 1, 1997

Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's diseaseK S Bankiewicz, S E Leff, D Nagy, et al.

Molecular Pharmacology|February 1, 1992

Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathioneS W Leslie, L M Brown, R D Trent, et al.

Gene Therapy|May 9, 2014

Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathwaysS E Gombash, F P Manfredsson, R J Mandel, et al.

Nature Biotechnology|August 14, 1998

Regulation of gene expression in vivo following transduction by two separate rAAV vectorsK G Rendahl, S E Leff, G R Otten, et al.

Pageof 10